Code of Standards
Discussion Board
About
IDEA Council
Become a Member
Membership
Become a Member
Our Members
Member Dashboard
Discussion Boards (Members Only)
Chapters
Canada
Central Atlantic
North Atlantic
North Central
South Atlantic
South Central
West
Events
Upcoming Events
Chapter Happenings
CRC 2023
CRC Venue
Register
CRC Exhibitors & Sponsors
CRC Presenters
CRC Schedule
The Leadership Event - August 1 - 3, 2023
Venue
Register
Schedule
Presenters
Education
Conference & Webinar Recordings
Town Hall Archive
Sponsored Webinars
Find or Post a Job
Master's Programs - MR & Data Analytics
Insights Podcast Network
IPC Directory
IA Laureates
Education Providers
Naomi Henderson Legacy Award
ResearchRockstarIPC
Resources
Industry Reports
Code of Standards
Benchmarking Surveys
Blue Book Buyer's Guide
Business Impact of Insights
ISO Certification
ISO 20252 Standard (Market Research)
ISO 20252 - Implementation Support
ISO 27001 Standard (Information Security)
Privacy Shield
About the Frameworks
How to Join
Application
Information for EU/Swiss Citizens to file a complaint
Annual Report 2022
Sponsor & Exhibit
Professional Liability Insurance
Model Contracts & Clauses
Insights & Analytics Market Report
Data Integrity Toolkit
Data Integrity Initiative
Data Integrity Initiative Resources
PAIR
Government Affairs
Protecting the Profession
Advocacy Successes
Position Papers
Legal Affairs
Bill Tracker
GDPR Portal
CCPA/CPRA Portal
News & Updates
Articles
Industry News
Register
Login
Membership
Become a Member
Our Members
Member Dashboard
Discussion Boards (Members Only)
Chapters
Canada
Central Atlantic
North Atlantic
North Central
South Atlantic
South Central
West
Events
Upcoming Events
Chapter Happenings
CRC 2023
CRC Venue
Register
CRC Exhibitors & Sponsors
CRC Presenters
CRC Schedule
The Leadership Event - August 1 - 3, 2023
Venue
Register
Schedule
Presenters
Education
Conference & Webinar Recordings
Town Hall Archive
Sponsored Webinars
Find or Post a Job
Master's Programs - MR & Data Analytics
Insights Podcast Network
IPC Directory
IA Laureates
Education Providers
Naomi Henderson Legacy Award
ResearchRockstarIPC
Resources
Industry Reports
Code of Standards
Benchmarking Surveys
Blue Book Buyer's Guide
Business Impact of Insights
ISO Certification
ISO 20252 Standard (Market Research)
ISO 20252 - Implementation Support
ISO 27001 Standard (Information Security)
Privacy Shield
About the Frameworks
How to Join
Application
Information for EU/Swiss Citizens to file a complaint
Annual Report 2022
Sponsor & Exhibit
Professional Liability Insurance
Model Contracts & Clauses
Insights & Analytics Market Report
Data Integrity Toolkit
Data Integrity Initiative
Data Integrity Initiative Resources
PAIR
Government Affairs
Protecting the Profession
Advocacy Successes
Position Papers
Legal Affairs
Bill Tracker
GDPR Portal
CCPA/CPRA Portal
News & Updates
Articles
Industry News
Articles
Archive by tag:
healthcare
Return
31
May
Fighting for You: May 2023 Legislative & Regulatory Update
Howard Fienberg
|
31 May, 2023
|
data privacy
,
data security
,
maryland
,
new york
,
human resources
,
census
,
independent contractors
,
incentives
,
artificial intelligence
,
washington
,
healthcare
,
telephone
,
tax
,
california
,
louisiana
,
minors
,
rhode island
,
indiana
,
iowa
|
Government Affairs
|
As temperatures rose, so did the threats and opportunities for the insights industry in advocacy during May, ranging from three new comprehensive state privacy laws, advancing regulation of artificial intelligence, compliance concerns with state sales taxes, jousting over the Census Household Panel, restrictions on high-end incentives for research subjects, state legislation to ban non-competes, and a new Maryland law restricting most telephone calls for research purposes.
Read More
30
Sep
Fighting for You: September 2022 Legislative and Regulatory Update
Howard Fienberg
|
30 Sep, 2022
|
data collection
,
census
,
data privacy
,
data security
,
california
,
vermont
,
illinois
,
maryland
,
michigan
,
massachusetts
,
washington
,
human resources
,
contracts
,
healthcare
|
Government Affairs
|
Temperatures may be cooling as the calendar turns to autumn, but legislative issues are heating up as lawmakers get back to work following summer breaks. Here are some of the key issues we're engaged with at the national and state level on your behalf...
Read More
28
Feb
Pennsylvania Pharmaceutical Manufacturing Prohibited Gifts Act of 2021 - H.B. 593
Howard Fienberg
|
28 Feb, 2021
|
Pennsylvania
,
healthcare
,
Member Only
,
incentives
|
Government Affairs
|
Pennsylvania Rep. Mike Zabel (D-PA-163) reintroduced the Pharmaceutical Manufacturing Prohibited Gifts Act (H.B. 593), adding an amendment recommended by the Insights Association that would protect bona fide marketing research with health care professionals.
Read More
28
Oct
The Physician Payments Sunshine Act: The Insights Industry Position
Howard Fienberg
|
28 Oct, 2014
|
sunshine
,
pharmaceutical
,
incentives
,
healthcare
|
Government Affairs
|
On August 1, 2013, the first reporting period under the Physician Payment Sunshine Act began. Part of the Patient Protection and Affordable Care Act (aka, “Obamacare”), it requires pharmaceutical and medical device manufacturers to publicly report many types of payments made to physicians, which will be public. The Sunshine Act was intended to bring transparency to these relationships, to minimize manufacturers’ influence on physicians’ prescribing behavior.
Read More
14
Jul
New Texas health privacy law H.B. 300 more expansive than HIPAA
Howard Fienberg
|
14 Jul, 2011
|
texas
,
healthcare
,
data privacy
,
Member Only
|
Government Affairs
|
Texas governor, Rick Perry, has signed a new health bill, H.B. 300, into law that enforces new obligations in addition to the requirements of the HIPAA privacy rule. The law, which becomes effective September 1, 2012, provides an expansive definition of a covered entity and is likely to include non-covered entities under HIPAA, including survey researchers.
Read More
30
Jul
Guidelines for Adverse Event Reporting: The Pharmaceutical Market Research Context
Insights Association
|
30 Jul, 2007
|
pharmaceutical
,
data privacy
,
healthcare
|
Government Affairs
|
Pharmaceutical marketing research and data analytics companies should not be required to assume responsibility for formal reporting of adverse events (AEs) uncovered during routine pharmaceutical marketing research and data analytics in the U.S. because:
Read More
Members only Article - Please login to view
Email:
Password:
Login
Remember Login
Create Account
Forgot Password
Popular
Recent
IA Urges U.S. Labor Department to Treat Research Subjects as Independent Contractors
0 Comments
Specific and Measured Restrictions on Non-Compete Agreements Supported by the Insights Association
0 Comments
Congress Demands Transparency from the Census Bureau’s Ask U.S. Panel Project in Final FY23 Omnibus
0 Comments
Removing the Stuffing from Research
0 Comments
Fighting for You: May 2023 Legislative & Regulatory Update
0 Comments
IA Supports Robust Census Funding in FY24
0 Comments
Fighting for You - April 2023 Legislative and Regulatory Update
0 Comments
Data Quality in the Spotlight at IA's Annual Conference
0 Comments
Government Affairs
(121)
Industry News
(1)
Methods & Trends
(3)
Management & Operations
(2)
IPC Feature
(0)
idaho
New York
Data Security
fda
contractors
Branding
delaware
Florida
gdpr
Members Only